Advaxis, Inc. Stock Nasdaq
Equities
US0076242082
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | 692K | Sales 2023 | 13K | Capitalization | 7.94M |
---|---|---|---|---|---|
Net income 2022 | -38M | Net income 2023 | -48M | EV / Sales 2022 * | - |
Net cash position 2022 | 657K | Net Debt 2023 | 3.43M | EV / Sales 2023 | 875 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-0.08
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Ken Berlin
CEO | Chief Executive Officer | 59 | 18-04-22 |
- | - | ||
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
CHM | Chairman | 64 | 13-07-15 |
Roni Appel
CEO | Chief Executive Officer | 57 | 04-10-31 |
Murray Goldberg
BRD | Director/Board Member | 79 | 23-01-18 |
1st Jan change | Capi. | |
---|---|---|
+28.45% | 48.16B | |
-1.08% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.12% | 25.59B | |
-22.94% | 18.96B | |
+8.01% | 12.92B | |
+29.01% | 12.03B | |
-1.90% | 11.77B |